Fulcrum Therapeutics, Inc. (FULC)
NASDAQ·Healthcare·Biotechnology
$7.43
-3.82%
Mkt Cap $424.23M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | — | — | — | -$0.31 | -$0.31 | +0.00% | — | — |
| Q4 2025 Oct 29, 2025 | — | — | — | -$0.29 | -$0.31 | -6.90% | — | — |
| Q3 2025 Jul 29, 2025 | — | — | — | -$0.29 | -$0.28 | +3.45% | — | — |
| Q2 2025 May 1, 2025 | — | — | — | -$0.29 | -$0.28 | +3.45% | — | — |
| Q1 2025 Feb 25, 2025 | — | — | — | -$0.28 | -$0.31 | -10.71% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.40 | -$0.35 | +12.50% | — | — |
| Q3 2024 Jul 31, 2024 | $14.82M | $80.00M | +439.93% | $0.01 | $0.87 | +7060.49% | — | — |
| Q2 2024 May 13, 2024 | $36.54M | — | — | -$0.44 | -$0.43 | +2.27% | — | — |
| Q1 2024 Feb 27, 2024 | $460.00K | $871.00K | +89.35% | -$0.44 | -$0.40 | +9.09% | — | — |
| Q4 2023 Nov 7, 2023 | $460.00K | $759.00K | +65.00% | -$0.44 | -$0.39 | +11.36% | — | — |
| Q3 2023 Aug 3, 2023 | $1.12M | $880.00K | -21.43% | -$0.44 | -$0.38 | +13.64% | — | — |
| Q2 2023 Jun 23, 2023 | — | $685.00K | — | — | -$0.45 | — | — | — |
| Q2 2023 May 15, 2023 | $1.13M | $295.00K | -73.89% | -$0.47 | -$0.41 | +12.77% | — | — |
| Q4 2022 Nov 8, 2022 | $2.54M | $1.18M | -53.48% | -$0.62 | -$0.50 | +19.35% | — | — |
| Q3 2022 Aug 11, 2022 | $2.96M | $1.88M | -36.51% | -$0.66 | -$0.83 | -25.76% | — | — |
| Q2 2022 May 9, 2022 | $3.94M | $2.59M | -34.28% | -$0.63 | -$0.64 | -1.59% | — | — |
| Q1 2022 Mar 3, 2022 | $2.68M | $5.06M | +88.74% | -$0.65 | -$0.58 | +10.77% | — | — |
| Q4 2021 Nov 4, 2021 | $2.25M | $4.93M | +119.33% | -$0.64 | -$0.57 | +10.94% | — | — |
| Q3 2021 Aug 10, 2021 | $1.60M | $4.38M | +173.81% | -$0.65 | -$0.60 | +7.69% | — | — |
| Q2 2021 May 6, 2021 | $5.66M | $4.79M | -15.38% | -$0.66 | -$0.54 | +18.18% | — | — |